This is known as the “immunoscore” [27, 28], in which CD8+ T cell quantification at the tumor center and periphery can strongly predict the overall survival (OS) and well correlated with the traditional tumor-node-metastasis (TNM) staging and/or MSI status in patients with colorectal cancer [28-30]. This evidence concerns the gene CD8A and neoplasm.